SNDX · CIK 0001395937 · operating
Syndax Pharmaceuticals Inc (SNDX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.9 billion, Syndax Pharmaceuticals Inc is a small-cap company. The stock currently trades at $22.14, up 1.98% today, with a 52-week range of $8.58–$22.73.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-3.29 | $-3.29 | +11.6% | |
| 2024 | $-3.72 | $-3.72 | -24.8% | |
| 2023 | $-2.98 | $-2.98 | -21.1% | |
| 2022 | $-2.46 | $-2.46 | -634.8% | |
| 2021 | $0.46 | $0.48 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001193125-26-076536 | SEC ↗ |
| 2024-12-31 | 2025-03-03 | 0000950170-25-030394 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0000950170-24-021253 | SEC ↗ |
| 2022-12-31 | 2023-02-28 | 0000950170-23-005079 | SEC ↗ |
| 2021-12-31 | 2022-03-01 | 0001564590-22-008112 | SEC ↗ |
| 2020-12-31 | 2021-03-12 | 0001564590-21-012607 | SEC ↗ |
| 2019-12-31 | 2020-03-05 | 0001564590-20-009016 | SEC ↗ |
| 2018-12-31 | 2019-03-07 | 0001564590-19-006772 | SEC ↗ |
| 2017-12-31 | 2018-03-08 | 0001564590-18-004911 | SEC ↗ |
| 2016-12-31 | 2017-03-14 | 0001193125-17-081863 | SEC ↗ |